Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/14/2022
Surging Beigene Catches Case of Forex Flu (The Bamboo Works)
11/14/2022
Fundraising Continued to Drop in October, No Drugmaker Raised More Tha...
11/14/2022
Cyagen, Neurophth Ink $140 Million Deal For AI-Designed AAV Capsids
11/14/2022
CDE Issues the Technical Guidelines for Clinical R&D of Bispecific Ant...
11/14/2022
BioNTech and Fosun Pharma Receive Special Approvals for Omicron-BA.4/B...
11/14/2022
Snapshot of BMI System Financial Performance in 3Qs/2022
11/11/2022
CDE Issues the Work Procedures for Changes During Drug Registration Ap...
11/11/2022
NMPA Announces Package Insert Revision of Phloroglucinol Injection
11/11/2022
AstraZeneca Launches First Alexion Rare Disease Therapy for Patients i...
11/11/2022
NMPA Solicits Comments on the Special Rules for TCM Registration
11/11/2022
Harbour BioMed Enters into a License and Collaboration Agreement with ...
11/11/2022
Drug R&D and Product Registration News Digest November 2022 (2)
11/11/2022
Review of A Share-listed Chinese MedPharm Cos in Q3/2022
11/11/2022
PwC: Review of China's Pharmaceutical & Life Sciences M&A Deals in 202...
11/10/2022
AstraZeneca Reports Strong Quarterly Results with China Growth Despite...
11/10/2022
China's Biopharma Industry: Market Prospects, Investment Paths (China ...
11/10/2022
Under Geopolitics and Market Rout, Chinese Biotechs Center on Data Qua...
11/9/2022
Sanofi and Insilico Medicine Enter $1.2B Strategic Research Collaborat...
11/9/2022
China Issues the 14th Five-Year Plan for Universal Health Informatizat...
11/9/2022
Review of China's Commercial Health Insurance Sector Development 2007-...
11/8/2022
NMPA Solicits Comments on the Technical Guidelines for Clinical Resear...
11/8/2022
CDE Issues the Technical Guidelines for Alcohol Dose Dumping Tests in ...
11/8/2022
CDE Issues on the Q&As on Research Conditions of Dissolution Curve in ...
11/8/2022
CDE Solicits Comments on the Technical Guidelines for New Drug Benefit...
11/8/2022
HEC Barred from Selling Linagliptin Products following Patent Ruling (...
11/7/2022
Trends and Characteristics of New Drug Approvals in China, 2011–2021
11/7/2022
NMPA Solicits Comments on Documents Relating To e-Submission of Drug R...
11/6/2022
CBC to Build a $137 Million Biopharma Complex in Western Shanghai
11/6/2022
Eucure Inks Partnership with ISU ABXIS To Develop Tri-Specific Antibod...
11/6/2022
China to Approve BioNTech's Covid-19 Vaccine for Foreigners with Pathw...
Page:
66
/
719
Total number of articles:
21546
:
[First]
[<<]
[64]
[65]
[66]
[67]
[68]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit